List of Tables
Table 1. Global Chagas Disease Drug Sales (K Pcs) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Chagas Disease Drug Sales (K Pcs) Comparison by Application (2021-2027)
Table 3. Global Chagas Disease Drug Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Chagas Disease Drug Covered in This Study
Table 5. Global Chagas Disease Drug Sales (K Pcs) of Key Manufacturers (2016-2021)
Table 6. Global Chagas Disease Drug Sales Share by Manufacturers (2016-2021)
Table 7. Global Chagas Disease Drug Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Chagas Disease Drug Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Chagas Disease Drug Average Price (USD/Pcs) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Chagas Disease Drug Manufacturing Sites and Area Served
Table 11. Manufacturers Chagas Disease Drug Product Type
Table 12. Global Chagas Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Chagas Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chagas Disease Drug as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Chagas Disease Drug Sales by Region (2016-2021) & (K Pcs)
Table 16. Global Chagas Disease Drug Sales Market Share by Region (2016-2021)
Table 17. Global Chagas Disease Drug Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Chagas Disease Drug Sales by Country (2016-2021) & (K Pcs)
Table 19. North America Chagas Disease Drug Sales Market Share by Country (2016-2021)
Table 20. North America Chagas Disease Drug Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Chagas Disease Drug Revenue Market Share by Country (2016-2021)
Table 22. Europe Chagas Disease Drug Sales by Country (2016-2021) & (K Pcs)
Table 23. Europe Chagas Disease Drug Sales Market Share by Country (2016-2021)
Table 24. Europe Chagas Disease Drug Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Chagas Disease Drug Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Chagas Disease Drug Sales by Region (2016-2021) & (K Pcs)
Table 27. Asia Pacific Chagas Disease Drug Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Chagas Disease Drug Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Chagas Disease Drug Revenue Market Share by Region (2016-2021)
Table 30. Latin America Chagas Disease Drug Sales by Country (2016-2021) & (K Pcs)
Table 31. Latin America Chagas Disease Drug Sales Market Share by Country (2016-2021)
Table 32. Latin America Chagas Disease Drug Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Chagas Disease Drug Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Chagas Disease Drug Sales by Country (2016-2021) & (K Pcs)
Table 35. Middle East and Africa Chagas Disease Drug Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Chagas Disease Drug Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Chagas Disease Drug Revenue Market Share by Country (2016-2021)
Table 38. Global Chagas Disease Drug Sales (K Pcs) by Type (2016-2021)
Table 39. Global Chagas Disease Drug Sales Market Share by Type (2016-2021)
Table 40. Global Chagas Disease Drug Revenue (Million US$) by Type (2016-2021)
Table 41. Global Chagas Disease Drug Revenue Share by Type (2016-2021)
Table 42. Global Chagas Disease Drug Price (USD/Pcs) by Type (2016-2021)
Table 43. Global Chagas Disease Drug Sales (K Pcs) by Application (2016-2021)
Table 44. Global Chagas Disease Drug Sales Market Share by Application (2016-2021)
Table 45. Global Chagas Disease Drug Revenue (Million US$) by Application (2016-2021)
Table 46. Global Chagas Disease Drug Revenue Share by Application (2016-2021)
Table 47. Global Chagas Disease Drug Price (USD/Pcs) by Application (2016-2021)
Table 48. AstraZeneca Plc Corporation Information
Table 49. AstraZeneca Plc Description and Business Overview
Table 50. AstraZeneca Plc Chagas Disease Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 51. AstraZeneca Plc Chagas Disease Drug Product
Table 52. AstraZeneca Plc Recent Developments/Updates
Table 53. Bayer AG Corporation Information
Table 54. Bayer AG Description and Business Overview
Table 55. Bayer AG Chagas Disease Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 56. Bayer AG Chagas Disease Drug Product
Table 57. Bayer AG Recent Developments/Updates
Table 58. Daiichi Sankyo Co Ltd Corporation Information
Table 59. Daiichi Sankyo Co Ltd Description and Business Overview
Table 60. Daiichi Sankyo Co Ltd Chagas Disease Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 61. Daiichi Sankyo Co Ltd Chagas Disease Drug Product
Table 62. Daiichi Sankyo Co Ltd Recent Developments/Updates
Table 63. Eisai Co Ltd Corporation Information
Table 64. Eisai Co Ltd Description and Business Overview
Table 65. Eisai Co Ltd Chagas Disease Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 66. Eisai Co Ltd Chagas Disease Drug Product
Table 67. Eisai Co Ltd Recent Developments/Updates
Table 68. GlaxoSmithKline Plc Corporation Information
Table 69. GlaxoSmithKline Plc Description and Business Overview
Table 70. GlaxoSmithKline Plc Chagas Disease Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 71. GlaxoSmithKline Plc Chagas Disease Drug Product
Table 72. GlaxoSmithKline Plc Recent Developments/Updates
Table 73. Grupo Praxis Pharmaceutical SA Corporation Information
Table 74. Grupo Praxis Pharmaceutical SA Description and Business Overview
Table 75. Grupo Praxis Pharmaceutical SA Chagas Disease Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 76. Grupo Praxis Pharmaceutical SA Chagas Disease Drug Product
Table 77. Grupo Praxis Pharmaceutical SA Recent Developments/Updates
Table 78. Humanigen Inc Corporation Information
Table 79. Humanigen Inc Description and Business Overview
Table 80. Humanigen Inc Chagas Disease Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 81. Humanigen Inc Chagas Disease Drug Product
Table 82. Humanigen Inc Recent Developments/Updates
Table 83. Kancera AB Corporation Information
Table 84. Kancera AB Description and Business Overview
Table 85. Kancera AB Chagas Disease Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 86. Kancera AB Chagas Disease Drug Product
Table 87. Kancera AB Recent Developments/Updates
Table 88. Merck & Co Inc Corporation Information
Table 89. Merck & Co Inc Description and Business Overview
Table 90. Merck & Co Inc Chagas Disease Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 91. Merck & Co Inc Chagas Disease Drug Product
Table 92. Merck & Co Inc Recent Developments/Updates
Table 93. Novartis AG Corporation Information
Table 94. Novartis AG Description and Business Overview
Table 95. Novartis AG Chagas Disease Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 96. Novartis AG Chagas Disease Drug Product
Table 97. Novartis AG Recent Developments/Updates
Table 98. Oblita Therapeutics BVBA Corporation Information
Table 99. Oblita Therapeutics BVBA Description and Business Overview
Table 100. Oblita Therapeutics BVBA Chagas Disease Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 101. Oblita Therapeutics BVBA Chagas Disease Drug Product
Table 102. Oblita Therapeutics BVBA Recent Developments/Updates
Table 103. Sanofi Corporation Information
Table 104. Sanofi Description and Business Overview
Table 105. Sanofi Chagas Disease Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 106. Sanofi Chagas Disease Drug Product
Table 107. Sanofi Recent Developments/Updates
Table 108. Production Base and Market Concentration Rate of Raw Material
Table 109. Key Suppliers of Raw Materials
Table 110. Chagas Disease Drug Distributors List
Table 111. Chagas Disease Drug Customers List
Table 112. Chagas Disease Drug Market Trends
Table 113. Chagas Disease Drug Growth Drivers
Table 114. Chagas Disease Drug Market Restraints
Table 115. Global Chagas Disease Drug Sales Forecast by Type (2022-2027) & (K Pcs)
Table 116. Global Chagas Disease Drug Sales Market Share Forecast by Type (2022-2027)
Table 117. Global Chagas Disease Drug Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 118. Global Chagas Disease Drug Revenue Market Share Forecast by Type (2022-2027)
Table 119. Global Chagas Disease Drug Sales Forecast by Application (2022-2027) & (K Pcs)
Table 120. Global Chagas Disease Drug Sales Market Share Forecast by Application (2022-2027)
Table 121. Global Chagas Disease Drug Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 122. Global Chagas Disease Drug Revenue Market Share Forecast by Application (2022-2027)
Table 123. Global Chagas Disease Drug Sales Forecast by Region (2022-2027) & (K Pcs)
Table 124. Global Chagas Disease Drug Sales Market Share Forecast by Region (2022-2027)
Table 125. Global Chagas Disease Drug Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 126. Global Chagas Disease Drug Revenue Market Share Forecast by Region (2022-2027)
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Chagas Disease Drug
Figure 2. Global Chagas Disease Drug Market Share by Type in 2020 & 2027
Figure 3. Cz-007 Product Picture
Figure 4. Cz-008 Product Picture
Figure 5. D-121 Product Picture
Figure 6. DNDI-0690 Product Picture
Figure 7. EPLBS-1246 Product Picture
Figure 8. EPLBS-967 Product Picture
Figure 9. Others Product Picture
Figure 10. Global Chagas Disease Drug Market Share by Application in 2020 & 2027
Figure 11. Hospital
Figure 12. Clinic
Figure 13. Others
Figure 14. Global Chagas Disease Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Chagas Disease Drug Market Size 2016-2027 (US$ Million)
Figure 16. Global Chagas Disease Drug Sales 2016-2027 (K Pcs)
Figure 17. Global Chagas Disease Drug Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 18. Chagas Disease Drug Sales Share by Manufacturers in 2020
Figure 19. Global Chagas Disease Drug Revenue Share by Manufacturers in 2020
Figure 20. The Global 5 and 10 Largest Chagas Disease Drug Players: Market Share by Revenue in 2020
Figure 21. Chagas Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 22. Global Chagas Disease Drug Sales Market Share by Region (2016-2021)
Figure 23. Global Chagas Disease Drug Sales Market Share by Region in 2020
Figure 24. Global Chagas Disease Drug Revenue Market Share by Region (2016-2021)
Figure 25. Global Chagas Disease Drug Revenue Market Share by Region in 2020
Figure 26. U.S. Chagas Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Canada Chagas Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Germany Chagas Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. France Chagas Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. U.K. Chagas Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Italy Chagas Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Russia Chagas Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. China Chagas Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Japan Chagas Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. South Korea Chagas Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. India Chagas Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Australia Chagas Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Taiwan Chagas Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Indonesia Chagas Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Thailand Chagas Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Malaysia Chagas Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Philippines Chagas Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Vietnam Chagas Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Mexico Chagas Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Brazil Chagas Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Argentina Chagas Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Turkey Chagas Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Saudi Arabia Chagas Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. U.A.E Chagas Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Sales Market Share of Chagas Disease Drug by Type (2016-2021)
Figure 51. Sales Market Share of Chagas Disease Drug by Application (2016-2021)
Figure 52. Sales Market Share of Chagas Disease Drug by Application in 2020
Figure 53. Revenue Share of Chagas Disease Drug by Application (2016-2021)
Figure 54. Revenue Share of Chagas Disease Drug by Application in 2020
Figure 55. Manufacturing Cost Structure of Chagas Disease Drug
Figure 56. Manufacturing Process Analysis of Chagas Disease Drug
Figure 57. Chagas Disease Drug Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed

LIST OF FIGURE